All Episodes — Pearls and Prep | Psychiatric Case Studies

Oct 17, 2026 Strattera (Atomoxetine) vs Wellbutrin (Bupropion): Non-Stimulant Uses | PMHNP Boards

💎 Stimulants are still first line for ADHD; Strattera is the move when they're off the table.

📇 Street Takes — scan the index card

Stimulants are still first line for ADHD; Strattera is the move when they're off the table.
Strattera needs weeks to work, not an hour — set expectations before your patient calls it a failure.
Once it's dialed in, Strattera covers ADHD around the clock — no late-afternoon wear-off cliff.
ADHD is the target? Strattera is FDA-approved for it. Wellbutrin isn't — its home turf is depression.
Seizure history or an eating disorder kills Wellbutrin. Prominent anxiety isn't an automatic no — but it's activating, so weigh it carefully.

Oct 13, 2026 Saphris (Asenapine): Bipolar Mania & Schizophrenia Prescribing | PMHNP Boards

💎 Saphris is the overlooked antipsychotic — its niches are bipolar I mania, mixed episodes, and schizophrenia.

📇 Street Takes — scan the index card

Saphris is the overlooked antipsychotic — its niches are bipolar I mania, mixed episodes, and schizophrenia.
It's dosed sublingually — with Saphris, the route isn't a detail, it's the whole ballgame.
Its receptor profile is genuinely unusual among SGAs — learn it, and the niche makes sense.
Don't just follow the algorithm: Saphris rewards clinicians who know why it fits their patient.

Oct 11, 2026 Wellbutrin (Bupropion) vs Trintellix (Vortioxetine) After SSRI Failure | PMHNP Boards

💎 Improved scores, flat life? Separate residual depression from SSRI emotional blunting — they demand opposite moves.

📇 Street Takes — scan the index card

Improved scores, flat life? Separate residual depression from SSRI emotional blunting — they demand opposite moves.
Blunting is a serotonergic side effect — more of the same SSRI won't fix it.
Wellbutrin's the pivot for flat and unmotivated: dopaminergic, activating, no sexual side effects.
Trintellix's case is cognition — multimodal serotonergic, with actual pro-cognitive data behind it.
Name the flatness with your patient — 'this has a name and a fix' — and buy-in follows.

Oct 6, 2026 Vraylar (Cariprazine) vs Abilify (Aripiprazole): D2, D3 Differences | PMHNP Boards

💎 Both are partial agonists — dimmer switches, not on/off blockers — so expect less EPS and prolactin trouble.

📇 Street Takes — scan the index card

Both are partial agonists — dimmer switches, not on/off blockers — so expect less EPS and prolactin trouble.
The real split is D3: Vraylar leans hard into reward circuits, Abilify splits D2 and D3 evenly.
Negative symptoms running the show? Vraylar has the mechanism and the strongest evidence in its class.
Vraylar's tail lasts weeks: forgiving with missed doses, slow to forgive when side effects hit.
New gambling or shopping sprees on Abilify? That's the FDA impulse-control warning — ask directly.

Sep 29, 2026 Panic Disorder vs PTSD: Differential Diagnosis Case Study | PMHNP Boards

💎 The differential is what they're avoiding: the panic attack itself, or the trauma reminder.

📇 Street Takes — scan the index card

The differential is what they're avoiding: the panic attack itself, or the trauma reminder.
Ask one question: 'Are you running from the feeling, or from the memory?' It often settles it.
Panic attacks inside PTSD are expected when trauma-cued — the trigger, not their presence, settles it.
Avoiding driving after a witnessed crash looks like PTSD — until you learn they fear another attack.
Panic avoidance clusters where escape is hard: crowds, highways, being alone. Trauma avoidance clusters around reminders.

Sep 22, 2026 Schizoid vs Schizotypal Personality Disorder: Clinical Clues | PMHNP Boards

Sep 15, 2026 Latuda (Lurasidone): When It Shines & When It Falls Short | PMHNP Boards

💎 Latuda without food is a fraction of the dose — write 'with at least 350 calories' on every script.

📇 Street Takes — scan the index card

Latuda without food is a fraction of the dose — write 'with at least 350 calories' on every script.
Absorption doubles or triples with a real meal; most 'non-responders' are just underdosed.
Where it shines: bipolar depression and schizophrenia, with a friendlier metabolic profile than most SGAs.
Akathisia and nausea are the tolerability watch-outs — ask about them early, not at month three.
If Latuda 'isn't working,' audit the meal before you audit the molecule.

Sep 8, 2026 Effexor (Venlafaxine) vs Cymbalta (Duloxetine): SNRI Differences | PMHNP Boards

💎 Never flip a coin between SNRIs — match the drug to what else the patient carries.

📇 Street Takes — scan the index card

Never flip a coin between SNRIs — match the drug to what else the patient carries.
Depressed and hurting? Cymbalta carries the pain indications: neuropathic pain, fibromyalgia, musculoskeletal pain.
Effexor past 225 mg a day can push blood pressure — check baseline BP with either SNRI.
Venlafaxine discontinuation is notoriously rough — counsel the slow taper before you ever start it.
Both activate and both can raise BP — the comorbidity, not the depression score, decides.

Sep 4, 2026 Psychiatric Interview Skills: 4 Techniques for New PMHNPs | PMHNP Boards

💎 Structure your intake — a framework is what keeps evaluations organized instead of wandering.

📇 Street Takes — scan the index card

Structure your intake — a framework is what keeps evaluations organized instead of wandering.
Rapport is a skill, not a personality trait — build it deliberately with every patient.
Train your eye for clinical clues: what matters often isn't the chief complaint itself.
Ask sharper questions — reasoning, not scripts, is what separates a real evaluation.

Sep 1, 2026 Long-Acting Injectables (LAIs) in Psychiatry: Benefits Explained | PMHNP Boards

💎 LAIs bypass first-pass metabolism — steadier levels, fewer peaks, and no daily GI absorption swings.

📇 Street Takes — scan the index card

LAIs bypass first-pass metabolism — steadier levels, fewer peaks, and no daily GI absorption swings.
A missed injection is data: nonadherence stops being a mystery and becomes visible immediately.
Offer LAIs early — first episode, chaotic schedule, patient preference — not as a last resort.
Fewer relapses and hospitalizations in real-world data — largely because adherence becomes visible instead of assumed.
'A pill every day or a shot every month?' Frame it as a choice, not a consequence.

Aug 25, 2026 False Positive Drug Screens: What Psychiatric Providers Must Know | PMHNP Boards

💎 A drug screen is a screening test, not a verdict — confirm before it changes a patient's life.

📇 Street Takes — scan the index card

A drug screen is a screening test, not a verdict — confirm before it changes a patient's life.
Jimmy screened positive for benzodiazepines he'd never taken — and it upended his entire treatment plan.
The error usually lives in communication — med lists and assumptions — not the patient's honesty.
Never let an unconfirmed result drive a clinical or legal consequence for your patient.

Aug 11, 2026 ADHD vs Bipolar Disorder: Key Questions for Differential Diagnosis | PMHNP Boards

Aug 10, 2026 Insomnia in Psychiatric Patients: Depression, Anxiety, ADHD & Trauma | PMHNP Boards

Aug 8, 2026 Effexor (Venlafaxine): When & Why to Choose This SNRI | PMHNP Boards

Aug 4, 2026 Metformin for Antipsychotic Weight Gain: An Easy Win | PMHNP Boards

Aug 3, 2026 Prozac (Fluoxetine) vs Zoloft (Sertraline): Real SSRI Differences | PMHNP Boards

💎 Efficacy is a tie — you choose on half-life, interactions, and the patient's life, not strength.

📇 Street Takes — scan the index card

Efficacy is a tie — you choose on half-life, interactions, and the patient's life, not strength.
Prozac tapers itself: its metabolite lingers one to two weeks, so missed doses barely register.
Stopping Prozac? Wait five full weeks before an MAOI — the tail outlasts the prescription.
Zoloft is the cardiac and polypharmacy pick — post-MI safety data and a cleaner interaction profile.
Prozac activates, Zoloft leans GI-heavy — match the side-effect profile to the patient in front of you.

Jul 31, 2026 PTSD vs Depression vs Adjustment Disorder: Differential Diagnosis | PMHNP Boards

Jul 30, 2026 Choosing Antipsychotics for Bipolar Disorder: 4 Prescribing Pearls | PMHNP Boards

Jul 28, 2026 Antipsychotic Switching: Key Concepts & Clinical Considerations | PMHNP Boards

Jul 26, 2026 Psychopharmacology Made Simple: The Grocery Store Trick | PMHNP Boards

Jul 24, 2026 Bipolar Relapse Prevention: The Polarity Index Explained | PMHNP Boards

Jul 23, 2026 Abilify (Aripiprazole) for Depression: Augmentation Explained | PMHNP Boards

Jul 22, 2026 The Polarity Index: Choosing Bipolar Maintenance Medications | PMHNP Boards

Jul 21, 2026 Naltrexone & the Sinclair Method for Alcohol Use Disorder | PMHNP Boards

Jul 16, 2026 ADHD Stimulants Explained: 5 Prescribing Pearls | PMHNP Boards

Jul 15, 2026 PMDD: Why SSRIs Work in Days — Diagnosis & Luteal-Phase Dosing | PMHNP Boards

Jul 14, 2026 Caffeine & Mood Disorders: The Detail That Derails Treatment | PMHNP Boards

Jul 13, 2026 CYP450 for Psychiatric Prescribers: 3 Clinical Pearls | PMHNP Boards

Jul 11, 2026 Same SSRI Dose, Different Outcomes: CYP Enzymes & Protein Binding | PMHNP Boards

Jul 7, 2026 Antidepressant Not Working? 4 Questions to Ask First (Zoloft Case) | PMHNP Boards

Jul 5, 2026 Irritability Differential Diagnosis: Depression, ADHD, Bipolar & More | PMHNP Boards

Jul 1, 2026 Z-Drugs (Zolpidem, Eszopiclone, Zaleplon): Prescribing Pearls | PMHNP Boards

Jun 30, 2026 Lexapro (Escitalopram): Efficacy & Tolerability Evidence | PMHNP Boards

Jun 23, 2026 Depersonalization vs Panic vs PTSD: Diagnostic Case Study | PMHNP Boards

Jun 19, 2026 Kratom: 5 Clinical Pearls for Psychiatric Providers | PMHNP Boards

Jun 16, 2026 ADHD Inattentive Type: DSM-5-TR Criteria Made Memorable | PMHNP Boards

Jun 15, 2026 DSM-5-TR Sleep-Wake Disorders: All 10 Categories Explained | PMHNP Boards

Jun 14, 2026 Adjustment Disorder: 5 Things Clinicians Get Wrong | PMHNP Boards

Jun 12, 2026 Paxil (Paroxetine) Withdrawal vs Depression Relapse | PMHNP Boards

Jun 11, 2026 Borderline Personality Disorder: A New Way to Understand BPD | PMHNP Boards

Jun 10, 2026 Cannabis-Induced Psychosis vs Schizophrenia: How to Tell | PMHNP Boards

Jun 9, 2026 Illness Anxiety vs Somatic Symptom vs Factitious vs Malingering | PMHNP Boards

Jun 8, 2026 ADHD vs Anxiety: The Differential That Changes Everything | PMHNP Boards

Jun 7, 2026 Personality Disorders: 4 Ways They Disrupt Treatment Plans | PMHNP Boards

Jun 6, 2026 Tardive Dyskinesia: How to Spot It & What to Do | PMHNP Boards

Jun 5, 2026 Tardive Dyskinesia Risk Factors: Who's Most at Risk? | PMHNP Boards

Jun 4, 2026 Benzos for Flying Phobia: Pharmacokinetics & Prescribing | PMHNP Boards

Jun 3, 2026 OCD vs PTSD vs GAD vs Psychosis: Differential Case Study | PMHNP Boards

Jun 2, 2026 Major Depressive Disorder with Psychotic Features: 6 Pearls | PMHNP Boards

Jun 1, 2026 Autoreceptors Explained: The Key to Psychopharmacology | PMHNP Boards

May 31, 2026 Topamax (Topiramate) Explained: A McDonald's Analogy | PMHNP Boards

May 30, 2026 Ferritin & Mental Health: The Lab That Mimics Half the DSM | PMHNP Boards

May 29, 2026 Hydroxyzine for Anxiety: The Misunderstood Non-Benzo Option | PMHNP Boards

May 28, 2026 Auvelity (Dextromethorphan-Bupropion): NMDA & Sigma-1 Explained | PMHNP Boards

May 27, 2026 Abilify (Aripiprazole) & Impulse Control: The Gambling Side Effect | PMHNP Boards

May 26, 2026 Major Depressive Disorder Specifiers: Mixed, Anxious & Melancholic | PMHNP Boards

May 25, 2026 Luvox (Fluvoxamine): Sigma-1 Receptors, OCD & Anxiety | PMHNP Boards

May 24, 2026 Serotonin, Dopamine & Norepinephrine: Choosing the Right Target | PMHNP Boards

May 23, 2026 OCD vs Delusional Disorder: A Tricky Case Study | PMHNP Boards

May 22, 2026 Antipsychotic Cross-Taper: 4 Switching Pearls | PMHNP Boards

May 21, 2026 OCD Gold Standard Treatment: What Most Clinicians Miss | PMHNP Boards

May 19, 2026 MDD with Mixed Features: Treatment When SSRIs Don't Fit | PMHNP Boards

May 18, 2026 Schizophrenia Negative Symptoms & Vraylar (Cariprazine): D3 Explained | PMHNP Boards

May 17, 2026 Schizophrenia Negative Symptoms: Board Bomb Case Study | PMHNP Boards

May 16, 2026 BPD vs Persistent Depressive Disorder: How to Tell Apart | PMHNP Boards

May 15, 2026 Trazodone: More Than a Sleep Med — Receptors & Prescribing | PMHNP Boards

May 14, 2026 Gabapentin in Psychiatry: Uses, Myths & Prescribing | PMHNP Boards

May 13, 2026 Specific Phobia: The Most Common Anxiety Disorder | PMHNP Boards

May 12, 2026 Post-Discharge Suicide Risk: The Most Dangerous Window | PMHNP Boards

May 11, 2026 Lamictal (Lamotrigine) vs Seroquel (Quetiapine) for Bipolar Depression | PMHNP Boards

💎 Board trap: Seroquel is FDA-approved for acute bipolar depression; Lamictal's approval is maintenance.

📇 Street Takes — scan the index card

Board trap: Seroquel is FDA-approved for acute bipolar depression; Lamictal's approval is maintenance.
Seroquel is the sprinter — works in weeks, and its sedation doubles as sleep treatment.
Lamictal can't be rushed: a slow five-to-six-week climb, and any new rash is stop-and-call.
Estrogen birth control cuts Lamictal levels roughly in half — psychopharmacology's most missed interaction.
Valproate doubles Lamictal levels — halve the Lamictal dose when the two ride together.

May 10, 2026 Antidepressant-Induced Bruxism: The Hidden Side Effect | PMHNP Boards

May 9, 2026 Bipolar Medication Mistakes: Board Bomb Case Study | PMHNP Boards

May 8, 2026 Depakote (Valproate) Toxicity: The Red Flag You Can't Miss | PMHNP Boards

May 7, 2026 Invega Sustenna (Paliperidone): LAI Initiation Board Bomb | PMHNP Boards

May 6, 2026 Positive Drug Screen on Psychiatric Meds: What Now? | PMHNP Boards

May 5, 2026 Spot the Medication Error: Mock Regimen Curveball | PMHNP Boards

May 4, 2026 Metformin with Antipsychotics (SGAs): The Underuse Problem | PMHNP Boards

May 1, 2026 Bipolar vs MDD with Psychosis: Board Bomb Diagnosis | PMHNP Boards

Apr 28, 2026 Acute Bipolar Depression: 5 Essential Medications | PMHNP Boards

Apr 27, 2026 Ambien (Zolpidem) ER Visits & Psych Med Pharmacokinetics | PMHNP Boards

Apr 26, 2026 Sleep Apnea & Depression: The Untreated Link Doubling Risk | PMHNP Boards

Apr 22, 2026 Affinity, Occupancy & Intrinsic Activity: Nightclub Analogy | PMHNP Boards